Skip to main content
Contact Us
Subscribe
E-Edition
57°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
StockStory
Stocktwits
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
EZ Newswire
FinancialNewsMedia
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
News Direct
Newsfile
NewsUSA
Newswire.com
Newsworthy.ai
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
Syndication Cloud
TheNewswire
Zexprwire
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
360 Privacy Secures $36 Million Growth Investment from FTV Capital
March 11, 2025
From
360 Privacy
Via
GlobeNewswire
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
March 11, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
PharmaTher Receives US FDA Approval Goal Date for Ketamine
March 11, 2025
From
PharmaTher Holdings Ltd.
Via
GlobeNewswire
Tickers
CSE:PHRM
PHRRF
Armlogi Holding Corp. Reports 20% Workforce Expansion Since Mid-2023
March 11, 2025
From
Armlogi Holding Corp
Via
GlobeNewswire
Tickers
BTOC
Jeffs’ Brands Enters Into a Definitive Agreement to Acquire a U.S. Company that Operates a U.S. Based Logistics Center, aiming to Advance its Growth Strategy, for $2.6 million
March 11, 2025
From
Jeffs' Brands Ltd
Via
GlobeNewswire
Tickers
JFBR
JFBRW
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
FuelCell Energy Reports First Quarter of Fiscal 2025 Results
March 11, 2025
From
FuelCell Energy, Inc.
Via
GlobeNewswire
Tickers
FCEL
Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients
March 11, 2025
From
Biogen Inc.
Via
GlobeNewswire
Tickers
BIIB
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Dyne Therapeutics to Present at Stifel 2025 Virtual CNS Forum
March 11, 2025
From
Dyne Therapeutics, Inc.
Via
GlobeNewswire
Tickers
DYN
OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
March 11, 2025
From
OptimizeRx Corporation
Via
GlobeNewswire
Tickers
OPRX
ProMIS Neurosciences to Participate in the 37th Annual Roth Conference
March 11, 2025
From
ProMIS Neurosciences Inc.
Via
GlobeNewswire
Tickers
PMN
TORRAS Powers Ahead in 2025: Building a Robust Low-Temperature Charging Ecosystem
March 11, 2025
From
TORRAS
Via
GlobeNewswire
Aurora Spine to Attend the American Academy of Orthopaedic Surgeons Annual Meeting
March 11, 2025
From
Aurora Spine Corporation
Via
GlobeNewswire
Tickers
ASAPF
TSX-V:ASG
Gauzy Ltd. Announces Record Fourth Quarter and Full Year 2024 Results
March 11, 2025
From
GAUZY LTD
Via
GlobeNewswire
Tickers
GAUZ
ECARX Announces Fourth Quarter and Full Year 2024 Unaudited Financial Results
March 11, 2025
From
ECARX LIMITED
Via
GlobeNewswire
Tickers
ECX
Legend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent Highlights
March 11, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Tickers
LEGN
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 11, 2025
From
Rapport Therapeutics, Inc.
Via
GlobeNewswire
Tickers
RAPP
Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 11, 2025
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
PyroGenesis and GE Vernova Sign Memorandum of Understanding (MOU)
March 11, 2025
From
PyroGenesis Inc.
Via
GlobeNewswire
Tickers
GEV
PYRGF
TSX:PYR
Monte Rosa Therapeutics to Present Pipeline Update and Release Fourth Quarter and Full Year 2024 Financial Results on March 20, 2025
March 11, 2025
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
Second Trader in Axi’s Capital Allocation Program, Axi Select, Secures $1,000,000 in Funding
March 11, 2025
From
AxiTrader Limited
Via
GlobeNewswire
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
March 11, 2025
From
Matinas BioPharma Holdings, Inc.
Via
GlobeNewswire
Tickers
GRCE
ONVO
Newton Golf Company Announces Name Change and 1-for-30 Reverse Stock Split
March 11, 2025
From
Newton Golf Company
Via
GlobeNewswire
Tickers
SPGC
Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum
March 11, 2025
From
Vigil Neuroscience, Inc.
Via
GlobeNewswire
Tickers
VIGL
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
March 11, 2025
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Tickers
HSDT
Axonius Announces Adapt Conference and Adapt In Action Roadshow
March 11, 2025
From
Axonius Inc.
Via
GlobeNewswire
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call
March 11, 2025
From
Cibus US LLC
Via
GlobeNewswire
Tickers
CBUS
Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market
March 11, 2025
From
Tilray Brands, Inc.
Via
GlobeNewswire
Tickers
TLRY
TSX:TLRY
Brookfield Closes Infrastructure Structured Solutions Fund
March 11, 2025
From
Brookfield Asset Management Ltd
Via
GlobeNewswire
Tickers
BAM
TSX:BAM
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.